Cetera Advisor Networks’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $704K | Sell |
8,061
-570
| -7% | -$49.8K | ﹤0.01% | 1691 |
|
|
2023
Q4 | $832K | Buy |
8,631
+1,462
| +20% | +$141K | ﹤0.01% | 1496 |
|
|
2023
Q3 | $634K | Sell |
7,169
-496
| -6% | -$43.9K | ﹤0.01% | 1606 |
|
|
2023
Q2 | $664K | Buy |
7,665
+1,283
| +20% | +$111K | ﹤0.01% | 1537 |
|
|
2023
Q1 | $621K | Sell |
6,382
-750
| -11% | -$72.9K | ﹤0.01% | 1556 |
|
|
2022
Q4 | $738K | Buy |
7,132
+405
| +6% | +$41.9K | 0.01% | 1371 |
|
|
2022
Q3 | $570K | Buy |
6,727
+1,264
| +23% | +$107K | 0.01% | 1197 |
|
|
2022
Q2 | $453K | Sell |
5,463
-62
| -1% | -$5.14K | 0.01% | 1333 |
|
|
2022
Q1 | $426K | Buy |
5,525
+1,530
| +38% | +$118K | 0.01% | 1402 |
|
|
2021
Q4 | $353K | Sell |
3,995
-3,416
| -46% | -$302K | ﹤0.01% | 1508 |
|
|
2021
Q3 | $573K | Buy |
7,411
+849
| +13% | +$65.6K | 0.01% | 1139 |
|
|
2021
Q2 | $548K | Buy |
6,562
+3,866
| +143% | +$323K | 0.01% | 1118 |
|
|
2021
Q1 | $204K | Buy |
+2,696
| New | +$204K | ﹤0.01% | 1363 |
|
|
2020
Q3 | – | Sell |
-1,959
| Closed | -$242K | – | 1427 |
|
|
2020
Q2 | $242K | Buy |
+1,959
| New | +$242K | 0.01% | 1016 |
|
|
2019
Q4 | – | Sell |
-3,434
| Closed | -$232K | – | 1246 |
|
|
2019
Q3 | $232K | Buy |
3,434
+28
| +0.8% | +$1.89K | 0.01% | 1032 |
|
|
2019
Q2 | $293K | Buy |
+3,406
| New | +$293K | 0.01% | 919 |
|
|
2014
Q4 | – | Sell |
-8,200
| Closed | -$588K | – | 825 |
|
|
2014
Q3 | $588K | Sell |
8,200
-1,150
| -12% | -$82.5K | 0.04% | 406 |
|
|
2014
Q2 | $579K | Buy |
+9,350
| New | +$579K | 0.04% | 421 |
|
|
2014
Q1 | – | Sell |
-6,924
| Closed | -$489K | – | 781 |
|
|
2013
Q4 | $489K | Sell |
6,924
-350
| -5% | -$24.7K | 0.04% | 411 |
|
|
2013
Q3 | $524K | Sell |
7,274
-230
| -3% | -$16.6K | 0.05% | 343 |
|
|
2013
Q2 | $417K | Buy |
+7,504
| New | +$417K | 0.04% | 354 |
|